Merck Free Cash Flow vs Investments Analysis

MRK Stock

USD 131.10 0.34 0.26%

Merck financial indicator trend analysis is infinitely more than just investigating Merck Company recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merck Company is a good investment. Please check the relationship between Merck Free Cash Flow and its Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Free Cash Flow vs Investments

Free Cash Flow vs Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merck Company Free Cash Flow account and Investments. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Merck's Free Cash Flow and Investments is -0.15. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Investments in the same time period over historical financial statements of Merck Company, assuming nothing else is changed. The correlation between historical values of Merck's Free Cash Flow and Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Merck Company are associated (or correlated) with its Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Investments has no effect on the direction of Free Cash Flow i.e., Merck's Free Cash Flow and Investments go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Most indicators from Merck's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Merck's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.18 this year, although the value of Tax Provision will most likely fall to about 2.2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	35.1B	41.9B	43.9B	46.1B
Total Revenue	48.7B	59.3B	59.9B	32.5B

Gross Profit Total Revenue

Merck fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Short Term Investments
Total Assets		0.57	0.72	0.79	0.87	0.53	0.28	0.88	0.73	1.0	0.22	0.74	0.61	0.3	0.74	0.93	0.59	0.15	0.7	0.98	0.3	0.8	0.49	0.27	0.95	0.16
Short Long Term Debt Total	0.57		0.92	0.75	0.25	0.89	0.91	0.75	0.2	0.59	0.69	0.11	0.9	-0.27	0.95	0.58	0.95	-0.55	0.97	0.5	0.27	0.24	0.76	0.75	0.64	-0.24
Other Current Liab	0.72	0.92		0.85	0.42	0.81	0.78	0.9	0.35	0.74	0.57	0.31	0.84	-0.19	0.94	0.71	0.89	-0.46	0.96	0.67	0.3	0.4	0.82	0.64	0.77	-0.1
Total Current Liabilities	0.79	0.75	0.85		0.4	0.61	0.6	0.93	0.42	0.81	0.64	0.28	0.63	-0.25	0.77	0.86	0.68	-0.43	0.82	0.73	0.52	0.37	0.86	0.4	0.87	-0.17
Total Stockholder Equity	0.87	0.25	0.42	0.4		0.33	-0.07	0.59	0.79	0.84	-0.17	0.9	0.43	0.67	0.47	0.72	0.36	0.57	0.4	0.9	0.08	0.93	0.05	0.1	0.72	0.37
Property Plant And Equipment Net	0.53	0.89	0.81	0.61	0.33		0.74	0.65	0.33	0.53	0.7	0.13	0.98	-0.14	0.84	0.57	0.93	-0.36	0.87	0.5	0.15	0.39	0.62	0.89	0.53	-0.4
Net Debt	0.28	0.91	0.78	0.6	-0.07	0.74		0.57	-0.21	0.33	0.65	-0.22	0.75	-0.51	0.8	0.28	0.84	-0.73	0.83	0.18	0.11	-0.09	0.73	0.71	0.41	-0.2
Retained Earnings	0.88	0.75	0.9	0.93	0.59	0.65	0.57		0.48	0.89	0.49	0.45	0.69	-0.14	0.82	0.84	0.76	-0.31	0.83	0.84	0.26	0.5	0.8	0.48	0.9	0.01
Cash	0.73	0.2	0.35	0.42	0.79	0.33	-0.21	0.48		0.69	0.1	0.8	0.35	0.54	0.38	0.75	0.24	0.44	0.35	0.8	0.41	0.81	0.11	0.07	0.6	-0.08
Non Current Assets Total	1.0	0.59	0.74	0.81	0.84	0.53	0.33	0.89	0.69		0.25	0.69	0.62	0.26	0.76	0.92	0.6	0.11	0.72	0.96	0.3	0.79	0.53	0.28	0.95	0.13
Non Currrent Assets Other	0.22	0.69	0.57	0.64	-0.17	0.7	0.65	0.49	0.1	0.25		-0.34	0.62	-0.63	0.53	0.4	0.63	-0.72	0.61	0.16	0.36	-0.09	0.8	0.71	0.3	-0.76
Cash And Short Term Investments	0.74	0.11	0.31	0.28	0.9	0.13	-0.22	0.45	0.8	0.69	-0.34		0.21	0.74	0.34	0.63	0.17	0.61	0.28	0.83	0.2	0.79	-0.1	-0.16	0.62	0.52
Net Receivables	0.61	0.9	0.84	0.63	0.43	0.98	0.75	0.69	0.35	0.62	0.62	0.21		-0.04	0.9	0.62	0.93	-0.29	0.91	0.57	0.13	0.47	0.6	0.83	0.62	-0.28
Common Stock Shares Outstanding	0.3	-0.27	-0.19	-0.25	0.67	-0.14	-0.51	-0.14	0.54	0.26	-0.63	0.74	-0.04		-0.05	0.23	-0.2	0.92	-0.12	0.38	0.08	0.67	-0.61	-0.38	0.19	0.47
Non Current Liabilities Total	0.74	0.95	0.94	0.77	0.47	0.84	0.8	0.82	0.38	0.76	0.53	0.34	0.9	-0.05		0.71	0.9	-0.34	0.99	0.68	0.27	0.47	0.7	0.63	0.79	-0.1
Inventory	0.93	0.58	0.71	0.86	0.72	0.57	0.28	0.84	0.75	0.92	0.4	0.63	0.62	0.23	0.71		0.55	0.03	0.72	0.92	0.53	0.72	0.57	0.25	0.94	-0.05
Other Current Assets	0.59	0.95	0.89	0.68	0.36	0.93	0.84	0.76	0.24	0.6	0.63	0.17	0.93	-0.2	0.9	0.55		-0.43	0.92	0.54	0.13	0.34	0.69	0.86	0.59	-0.19
Other Stockholder Equity	0.15	-0.55	-0.46	-0.43	0.57	-0.36	-0.73	-0.31	0.44	0.11	-0.72	0.61	-0.29	0.92	-0.34	0.03	-0.43		-0.42	0.23	-0.12	0.57	-0.74	-0.48	-0.03	0.46
Total Liab	0.7	0.97	0.96	0.82	0.4	0.87	0.83	0.83	0.35	0.72	0.61	0.28	0.91	-0.12	0.99	0.72	0.92	-0.42		0.64	0.35	0.4	0.75	0.66	0.77	-0.17
Total Current Assets	0.98	0.5	0.67	0.73	0.9	0.5	0.18	0.84	0.8	0.96	0.16	0.83	0.57	0.38	0.68	0.92	0.54	0.23	0.64		0.31	0.82	0.4	0.22	0.91	0.21
Short Term Debt	0.3	0.27	0.3	0.52	0.08	0.15	0.11	0.26	0.41	0.3	0.36	0.2	0.13	0.08	0.27	0.53	0.13	-0.12	0.35	0.31		0.12	0.3	-0.16	0.41	-0.27
Intangible Assets	0.8	0.24	0.4	0.37	0.93	0.39	-0.09	0.5	0.81	0.79	-0.09	0.79	0.47	0.67	0.47	0.72	0.34	0.57	0.4	0.82	0.12		0.07	0.16	0.65	0.15
Accounts Payable	0.49	0.76	0.82	0.86	0.05	0.62	0.73	0.8	0.11	0.53	0.8	-0.1	0.6	-0.61	0.7	0.57	0.69	-0.74	0.75	0.4	0.3	0.07		0.57	0.58	-0.37
Property Plant And Equipment Gross	0.27	0.75	0.64	0.4	0.1	0.89	0.71	0.48	0.07	0.28	0.71	-0.16	0.83	-0.38	0.63	0.25	0.86	-0.48	0.66	0.22	-0.16	0.16	0.57		0.22	-0.48
Common Stock Total Equity	0.95	0.64	0.77	0.87	0.72	0.53	0.41	0.9	0.6	0.95	0.3	0.62	0.62	0.19	0.79	0.94	0.59	-0.03	0.77	0.91	0.41	0.65	0.58	0.22		0.14
Short Term Investments	0.16	-0.24	-0.1	-0.17	0.37	-0.4	-0.2	0.01	-0.08	0.13	-0.76	0.52	-0.28	0.47	-0.1	-0.05	-0.19	0.46	-0.17	0.21	-0.27	0.15	-0.37	-0.48	0.14

Click cells to compare fundamentals

Merck Account Relationship Matchups

Merck fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	84.4B	91.6B	105.7B	109.2B	106.7B	60.3B
Short Long Term Debt Total	26.3B	31.8B	33.1B	30.7B	36.3B	38.1B
Other Current Liab	14.9B	16.3B	16.9B	18.0B	15.5B	16.3B
Total Current Liabilities	22.2B	27.3B	23.9B	24.2B	25.7B	13.3B
Total Stockholder Equity	25.9B	25.3B	38.2B	46.0B	37.6B	25.5B
Property Plant And Equipment Net	15.1B	18.0B	19.3B	21.4B	24.5B	25.7B
Net Debt	16.7B	23.7B	25.0B	18.0B	29.4B	30.8B
Retained Earnings	46.6B	47.4B	53.7B	61.1B	53.9B	32.6B
Cash	9.7B	8.1B	8.1B	12.7B	6.9B	5.6B
Non Current Assets Total	56.9B	63.8B	75.4B	73.4B	74.5B	41.1B
Non Currrent Assets Other	5.3B	9.2B	8.1B	7.7B	9.2B	6.1B
Cash And Short Term Investments	10.5B	8.1B	8.1B	13.2B	7.2B	7.3B
Net Receivables	6.8B	7.9B	9.2B	9.5B	11.1B	11.6B
Common Stock Shares Outstanding	2.6B	2.5B	2.5B	2.5B	2.5B	2.7B
Liabilities And Stockholders Equity	84.4B	91.6B	105.7B	109.2B	106.7B	60.3B
Non Current Liabilities Total	36.2B	38.9B	43.6B	38.9B	43.3B	45.5B
Inventory	6.0B	6.3B	6.0B	5.9B	6.4B	3.7B
Other Current Assets	4.3B	5.5B	7.0B	7.2B	7.6B	8.0B
Other Stockholder Equity	(16.3B)	(17.2B)	(12.9B)	(12.1B)	(12.9B)	(12.3B)
Total Liab	58.4B	66.2B	67.4B	63.1B	69.0B	72.5B
Total Current Assets	27.5B	27.8B	30.3B	35.7B	32.2B	19.2B
Short Term Debt	3.6B	6.4B	2.4B	1.9B	1.7B	2.3B
Intangible Assets	14.2B	14.6B	22.9B	20.3B	18.0B	14.3B
Accounts Payable	3.7B	4.6B	4.6B	4.3B	3.9B	2.8B
Property Plant And Equipment Gross	15.1B	18.0B	37.5B	39.4B	41.3B	43.4B
Accumulated Other Comprehensive Income	(6.2B)	(6.6B)	(4.4B)	(4.8B)	(5.2B)	(4.9B)
Short Term Investments	774M	1M	0.0	498M	252M	239.4M
Other Liab	12.7B	12.1B	11.7B	9.1B	10.5B	10.2B
Other Assets	5.3B	7.8B	9.4B	7.4B	8.5B	5.5B
Long Term Debt	22.7B	25.4B	30.7B	28.7B	33.7B	17.2B
Good Will	19.4B	20.2B	21.3B	21.2B	21.2B	12.3B
Treasury Stock	(56.0B)	(56.8B)	(57.1B)	(56.5B)	(57.5B)	(54.6B)
Property Plant Equipment	15.1B	18.0B	19.3B	21.4B	24.6B	16.2B
Net Tangible Assets	(7.7B)	(9.5B)	3.5B	4.5B	4.1B	4.5B
Noncontrolling Interest In Consolidated Entity	94M	87M	73M	67M	54M	51.3M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Merck Company using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

How To Invest In Merck

Details

Is Merck Stock a good investment?

Details

What is Merck's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.

	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities

Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.685

Dividend Share

2.96

Earnings Share

0.9

Revenue Per Share

24.215

Quarterly Revenue Growth

0.089

The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merck Free Cash Flow vs Investments Analysis

Free Cash Flow vs Investments

Free Cash Flow vs Investments Correlation Analysis

Correlation Coefficient

Free Cash Flow

Investments

Merck fundamental ratios Correlations

Merck Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Merck fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Merck Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Total Current Assets	+ 0.98	Total Assets
Net Receivables	+ 0.98	Property Plant And Equipment Net
Total Liab	+ 0.97	Short Long Term Debt Total
Total Liab	+ 0.96	Other Current Liab

Short Term Investments	- 0.76	Non Currrent Assets Other
Accounts Payable	- 0.74	Other Stockholder Equity
Other Stockholder Equity	- 0.73	Net Debt
Other Stockholder Equity	- 0.72	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.63	Non Currrent Assets Other
Accounts Payable	- 0.61	Common Stock Shares Outstanding